3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
3
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Breast Neoplasms
2
Urologic Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Patients With Advanced or Metastatic Solid Tumors
1
PRETEXT I Hepatoblastoma
1
Neurofibromatosis 2
1
Neoplasms, Mesothelial
1
Mouth Neoplasms
1
Melanoma
1
Lymphangioleiomyomatosis
1
Lung Neoplasms
1
Kidney Neoplasms
1
Glioma
1
Glioblastoma
1
Erdheim-Chester Disease
1
Endometrial Adenocarcinoma
1
Endocrine Gland Neoplasms
1
Colonic Neoplasms
1
Castleman Disease
1
Interventions
Oxaliplatin
24
Fluorouracil
20
Capecitabine
16
pembrolizumab
15
Nivolumab
15
Leucovorin
13
Trastuzumab
9
fludarabine
8
Paclitaxel
8
Drug Therapy
8
Docetaxel
8
Cyclophosphamide
8
S 1 (combination)
7
trastuzumab deruxtecan
6
Specimen Handling
6
Cisplatin
6
Magnetic Resonance Spectroscopy
5
Bevacizumab
5
zolbetuximab
4
Irinotecan
4
Biopsy
4
zimberelimab
3
sintilimab
3
fludarabine phosphate
3
atezolizumab
3
aldesleukin
3
XELOX
3
Surgical Procedures, Operative
3
Ramucirumab
3
Radiotherapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
temsirolimus
×
90 days
×
Clear all
No trials found.